Want to join the conversation?
$ALXN reiterated its 2016 total revenue guidance of $3.05-3.1Bil and its Soliris revenue outlook of $2.835-2.875Bil. The company now expects GAAP EPS of $1.91-2.26. $ALXN lowered its 2016 adjusted EPS guidance to range of $4.50-4.65 from previous forecast of low end of $5.00-5.20.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)